Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck

NCT03132038 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
98
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNICANCER